Psoriasis, Anti-Tumor Necrosis Factor Therapy, and Tuberculosis: Report of Three Challenging Cases and Literature Review

INTRODUCTION: The era of biologic therapies has provided new options for the treatment of chronic plaque psoriasis. However, safety concerns have led to intensive screening and monitoring of patients receiving anti-tumor necrosis factor alpha (anti-TNF-alpha) agents. METHODS: The authors describe th...

Descripción completa

Detalles Bibliográficos
Autores principales: Solovan, Caius, Chiticariu, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108098/
https://www.ncbi.nlm.nih.gov/pubmed/25135824
http://dx.doi.org/10.1007/s40121-013-0003-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108098/
https://www.ncbi.nlm.nih.gov/pubmed/25135824
http://dx.doi.org/10.1007/s40121-013-0003-9

Ejemplares similares